The fight against Neglected Tropical Diseases, one year after the London Declaration
On 30 January 2012, Sanofi joined a group of public and private partners to launch the London Declaration on Neglected Tropical Diseases (NTDs), pledging to control or eliminate 10 NTDs by 2020. This month marks the one-year anniversary of those commitments.
In 2012, this partnership has made significant progress: more than 40 countries developed multi-year integrated NTD plans and the world’s leading pharmaceutical companies provided 1.12 billion treatments for NTDs. These commitments fully met the increased requests from endemic country partners and removed a key bottleneck to the successful treatment and prevention of NTDs.
United to Combat Lymphatic Filariasis
In January 2012, Sanofi in partnership with Eisaï and the Bill & Melinda Gates Foundation joined the World Health Organization (WHO)’s Global Program to Eliminate Lymphatic Filariasis (or elephantiasis) by 2020 and, together, committed to donating 120 million tablets of DEC (diethylcarbamazine) during 2012-2013, allowing WHO to provide preventative treatment for 30 million people not previously covered by donation programs. In 2012, 60 million tablets were already provided to WHO for Malaysia, Madagascar and Myanmar.
Lymphatic Filariasis, commonly known as elephantiasis, is a threat to more than 1.3 billion people in 81 countries. More than 120 million people are currently infected, 40 million disfigured and incapacitated by the disease.
These numbers are more than just drugs delivered or funds committed. They ultimately mean that millions of people have been spared pain and suffering from these debilitating diseases.
Through new and innovative partnerships, we can continue to help break the cycle of poverty and overcome the burden of NTDs.